Stay updated on Seagen Press Releases

Sign up to get notified when there's something new on the Seagen Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Seagen Press Releases page

  1. Check
    4 days ago
    Change Detected
    Summary
    Four May 2026 press releases were added to the Newsroom, covering TALZENNA Plus XTANDI results in metastatic prostate cancer, LORBRENA CROWN trial results in advanced NSCLC, a global collaboration with Innovent Biologics to accelerate oncology medicines, and an investor webcast invitation.
    Difference
    8%
    Check dated 2026-05-30T20:36:54.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Adds a new press release entry titled 'Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results' dated 05.20.2026 under the Research and Pipeline category, expanding the page's current press listings. Removes 'Pfizer logo' and 'Finance' items from navigation/branding areas.
    Difference
    3%
    Check dated 2026-05-23T13:30:27.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A new HYMPAVZI press release is added to the May 2026 list, and the TALZENNA Plus XTANDI entry is removed from March 2026. The page header branding now includes the Pfizer logo and a branded tagline.
    Difference
    3%
    Check dated 2026-05-16T09:46:43.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Added a May 5, 2026 press release entry for Pfizer's first-quarter results and reaffirmed 2026 guidance, and removed the March 17, 2026 press release from the listing along with the 'Research' and 'Research and Pipeline' categories.
    Difference
    1%
    Check dated 2026-05-09T12:06:22.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    New April 2026 press releases were added—'Pfizer Reaches Three Settlement Agreements for VYNDAMAX' and 'Pfizer’s ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma'—and the category labels now include Finance, Corporate, and Prescription Medicines, while an older release was removed from the list.
    Difference
    4%
    Check dated 2026-05-02T09:28:10.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Updated the press release listings by adding several new April 2026 items (including Pfizer’s 2026 shareholder meeting preliminary results, a second-quarter dividend announcement, and FDA priority review for PADCEV™ + Keytruda®) and removing a set of older February 2026 press releases.
    Difference
    8%
    Check dated 2026-04-25T05:16:12.000Z thumbnail image

Stay in the know with updates to Seagen Press Releases

Enter your email address, and we'll notify you when there's something new on the Seagen Press Releases page.